CLINICAL_TRIALS
trial_result
· 2020-11-18
Clinical Trial Update: A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus [Phase 2]
Summary
A Phase 2 dose-finding trial of RO4998452 in patients with Type 2 diabetes has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2020-11-18